# Fecal Transplantation to Eradicate Colonizing Emergent Superbugs

> **NCT05035342** · PHASE3 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 214 (estimated)

## Conditions studied

- Enterobacteriaceae Infections
- Fecal Microbiota Transplantation

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplantation (FMT) capsules
- **BIOLOGICAL:** Placebo capsules

## Key facts

- **NCT ID:** NCT05035342
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-11
- **Primary completion:** 2026-05
- **Final completion:** 2028-04
- **Target enrollment:** 214 (ESTIMATED)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05035342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05035342, "Fecal Transplantation to Eradicate Colonizing Emergent Superbugs". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05035342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*